BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Lepodisiran readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Lepodisiran\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07914738-1040@assetmemo.bio
DTSTAMP:20261121T005644Z
DTSTART;VALUE=DATE:20270331
DTEND;VALUE=DATE:20270401
SUMMARY:Lepodisiran: Phase 1 readout est. (NCT07914738)
DESCRIPTION:Lepodisiran\, phase 1\, Atherosclerotic Cardiovascular Disease.
 \nStudy: A Study of Lepodisiran (LY3819469) in Participants With High Lipo
 protein(a)\nEstimated primary completion: March 2027. This is a ClinicalTr
 ials.gov estimate\, not a confirmed readout date\, and it can move.\nDrug 
 page: https://assetmemo.bio/drug/lepodisiran#upcoming-events\nRegistry rec
 ord: https://clinicaltrials.gov/study/NCT07914738
URL:https://assetmemo.bio/drug/lepodisiran#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06292013-1040@assetmemo.bio
DTSTAMP:20261121T005644Z
DTSTART;VALUE=DATE:20290331
DTEND;VALUE=DATE:20290401
SUMMARY:Lepodisiran: Phase 3 readout est. (NCT06292013)
DESCRIPTION:Lepodisiran\, phase 3\, Atherosclerotic Cardiovascular Disease.
 \nStudy: A Study to Investigate the Effect of Lepodisiran on the Reduction
  of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotei
 n(a) - ACCLAIM-Lp(a)\nEstimated primary completion: March 2029. This is a 
 ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can mo
 ve.\nDrug page: https://assetmemo.bio/drug/lepodisiran#upcoming-events\nRe
 gistry record: https://clinicaltrials.gov/study/NCT06292013
URL:https://assetmemo.bio/drug/lepodisiran#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07613294-1040@assetmemo.bio
DTSTAMP:20261121T005644Z
DTSTART;VALUE=DATE:20291231
DTEND;VALUE=DATE:20300101
SUMMARY:Lepodisiran: Phase 3 readout est. (NCT07613294)
DESCRIPTION:Lepodisiran\, phase 3\, Atherosclerotic Cardiovascular Disease.
 \nStudy: A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arter
 ies of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High
  Risk\nEstimated primary completion: December 2029. This is a ClinicalTria
 ls.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pa
 ge: https://assetmemo.bio/drug/lepodisiran#upcoming-events\nRegistry recor
 d: https://clinicaltrials.gov/study/NCT07613294
URL:https://assetmemo.bio/drug/lepodisiran#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
